The verified answer
As of Aug 2026, DEPLOY verifies LEM Surgical: 2 models, $49.0M raised, 2 active incidents. 1 source back the record.
CategorySurgical robots
Overview
Bern, Switzerland-based medical robotics company founded in 2021 by Prof. Dr. Stefan Weber, Prof. Dr. Andreas Raabe, Marco Matulic, Simon Michel, and Yossi Bar. LEM Surgical develops the Dynamis robotic surgical system, a next-generation integrated navigation-based platform for hard tissue and spine surgery. Showcased in NVIDIA's CES 2026 keynote. Raised CHF 22M in Series B funding.
Verified record
- Verified deployments
- None on file
- Active incidents
- 2 incidents on file
Key facts
FDA 510(k)
CEO
Co-founders
Series B
Product
Data & sources
Web sources
1
1 source backing this record.View all →
Models (2)
View all models →Current platform
Dynamis
Dynamis is a surgical robot from LEM Surgical, currently commercially available.
Current platform
Dynamis Robotic Surgical System
Bern, Switzerland-based medical robotics company founded in 2021 by Prof. Dr. Stefan Weber, Prof. Dr. Andreas Raabe, Marco Matulic, Simon Michel, and Yossi Bar. LEM Surgical develops the Dynamis robotic surgical system, a next-generation integrated navigation-based platform for hard tissue and spine surgery. Showcased in NVIDIA's CES 2026 keynote. Raised CHF 22M in Series B funding.
LEM Surgical on the deployment map
View the global mapLEM Surgical has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for LEM Surgical on the DEPLOY record yet. Track LEM Surgical to know the moment the first one is verified.
Current leadership (1)
- Yossi Bar Founder & CEOreported, not verified
Founders (1)
- Yossi Barcofounder
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting LEM Surgical (2)
- LEM Surgical receives FDA clearance for Dynamis multi-arm surgical robot2026-07-01 · Regulatory action
- LEM Surgical receives second FDA 510(k) clearance for next-gen robotic surgical system2026-06-23 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
LEM Surgical in third-party press
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Remebot2 models
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- early
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (2)
LEM Surgical’s 2 disclosed rounds, $49M in total, oldest to newest.
- Series B2025-01-01
$25M(reported)
- Series B2024-01-05
$24M(reported)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 2, 2026
Added to the verified registry
- Incident recordedJul 1, 2026
LEM Surgical receives FDA clearance for Dynamis multi-arm surgical robot
- Incident recordedJun 23, 2026
LEM Surgical receives second FDA 510(k) clearance for next-gen robotic surgical system
- Deployment verifiedVerifiedNov 1, 2025
Dynamis at Las Vegas, Nevada, USA
Sources (1)
Common questions
What is LEM Surgical?
What does LEM Surgical make?
Is LEM Surgical publicly traded?
Who competes with LEM Surgical?
Who is the CEO of LEM Surgical?
How can I invest in LEM Surgical?
Where is LEM Surgical headquartered?
How much funding has LEM Surgical raised?
Who owns LEM Surgical?
Where does LEM Surgical operate robots?
Is LEM Surgical a top robotics company?
Are there any incidents involving LEM Surgical?
Is LEM Surgical safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for LEM Surgical.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Remebot2 models
In the press
Recent coverage mentioning LEM Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
LEM Surgical announces FDA clearance of Dynamis robotic surgical system
LEM Surgical received FDA clearance for Dynamis, a first-of-its-kind multi-arm surgical robot for hard tissue surgery.
LEM Surgical Announces Second FDA 510k Clearance
LEM Surgical received its second FDA 510(k) clearance, marking the first time a surgical robot can independently and continuously track multiple instruments.
LEM Surgical wins new FDA clearance for humanoid surgical robot
LEM Surgical received its second FDA 510(k) clearance for the Dynamis robotic surgical system, adding individual vertebra tracking, bi-manual stabilization, and cervical…
LEM Surgical announces second FDA 510k clearance for Dynamis robotic surgical system
LEM Surgical received its second FDA 510k clearance for the Dynamis Robotic Surgical System, enabling simultaneous bilateral workflow and continuous independent tracking of…
'World's first' surgical humanoid robot masters spinal procedures
Switzerland-based LEM Surgical showcased its Dynamis surgical humanoid system at CES 2026, featuring a multi-arm architecture for spinal and orthopedic procedures with…
LEM Surgical wins FDA clearance for hard tissue surgical robot
LEM Surgical received FDA 510(k) clearance for its Dynamis robotic surgical system for hard tissue surgery. Showcased surgical humanoid at CES 2026 with NVIDIA Physical AI…
LEM Surgical Showcased in NVIDIA CES 2026 Keynote
LEM Surgical's Dynamis robotic surgical system was showcased in NVIDIA's CES 2026 keynote, highlighting the collaboration in AI-driven surgery.
LEM Surgical AG Secures CHF 22 Million in Series B Funding
LEM Surgical raised CHF 22M in Series B funding. Founded by team from CAScination AG and Ypsomed.
Machine-readable surfaces
- Markdown mirror: /companies/lem-surgical.md
- RSS feed: /companies/lem-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/2b651b74-6e01-4d10-8fc3-7bb18690e89c
- Revision history: /companies/lem-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Remebot2 models
Video
LEM Surgical’s Dynamis system is the first FDA‑cleared humanoid surgical platform for spine surgery. Using NVIDIA Isaac for Healthcare and Cosmos Transfer to tr
CES 2026 at the Nvidia Showcase Robotics Demo. LEM Surgical is focused on creating and providing the next generation of hard tissue robotic surgical systems. Da
With physical AI and simulation, Johnson & Johnson MedTech is advancing development of the MONARCH Platform. Using NVIDIA Isaac for Healthcare, powered by the N
For Educational purpose only! No copyright infringement intended All video parts are of the sole property of LEM Surgical
For Educational purpose only! No copyright infringement intended All video parts are of the sole property of LEM Surgical
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions
Yossi Bar and Christopher Prentice joined us in the LSI Studio at LSI USA ‘25 in Dana Point, California. LEM Surgical is a company that is focused on launching
Reality vs attention
LEM Surgical draws attention at the 83rd percentile but verifies reality at the 47th percentile among surgical robots. Hype Gap +35.7, 11th widest among surgical robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026